Pancreatic Cancer Research

ResearcherTokyo Medical and Dental UniversityNo recent work listed

Takeshi Ishii

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer. Co-author DOI 10.1111/cas.15615↗
  2. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer. Co-author DOI 10.1038/s41598-022-14297-5↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ayano Kabashima · 2 shared papers, 2022–2023 · strength 0.31
  2. Minoru Tanabe · 2 shared papers, 2022–2023 · strength 0.31
  3. Hiroaki Ono · 1 shared paper, 2023 · strength 0.16
  4. Shuichi Watanabe · 1 shared paper, 2023 · strength 0.16
  5. Daisuke Asano · 1 shared paper, 2023 · strength 0.16
  6. Kosuke Ogawa · 1 shared paper, 2023 · strength 0.16
  7. Shinji Tanaka · 1 shared paper, 2023 · strength 0.16
  8. Shinji Tanaka · 1 shared paper, 2022 · strength 0.16
  9. Atsushi Masamune · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.